291 related articles for article (PubMed ID: 26997214)
1. Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.
Dajani A; AbuHammour A
Saudi J Gastroenterol; 2016; 22(2):91-105. PubMed ID: 26997214
[TBL] [Abstract][Full Text] [Related]
2. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Sugimoto K; Inui H; Fukusato T
World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
[TBL] [Abstract][Full Text] [Related]
3. [Treatment Options in Non-alcoholic Fatty Liver Disease].
Kim W
Korean J Gastroenterol; 2017 Jun; 69(6):353-358. PubMed ID: 28637104
[TBL] [Abstract][Full Text] [Related]
4. Current treatment options for nonalcoholic fatty liver disease.
Shetty A; Syn WK
Curr Opin Gastroenterol; 2019 May; 35(3):168-176. PubMed ID: 30844893
[TBL] [Abstract][Full Text] [Related]
5. Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Gawrieh S; Chalasani N
Clin Liver Dis; 2018 Feb; 22(1):189-199. PubMed ID: 29128056
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic landscape of non-alcoholic steatohepatitis.
Perazzo H; Dufour JF
Liver Int; 2017 May; 37(5):634-647. PubMed ID: 27727520
[TBL] [Abstract][Full Text] [Related]
7. Position statement on the diagnosis and management of non-alcoholic fatty liver disease.
Alswat KA; Fallatah HI; Al-Judaibi B; Elsiesy HA; Al-Hamoudi WK; Qutub AN; Alturaify N; Al-Osaimi A
Saudi Med J; 2019 Jun; 40(6):531-540. PubMed ID: 31219486
[TBL] [Abstract][Full Text] [Related]
8. Reversal of NASH fibrosis with pharmacotherapy.
Alukal JJ; Thuluvath PJ
Hepatol Int; 2019 Sep; 13(5):534-545. PubMed ID: 31363910
[TBL] [Abstract][Full Text] [Related]
9. Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease.
Ganesh S; Rustgi VK
Clin Liver Dis; 2016 May; 20(2):351-64. PubMed ID: 27063274
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease.
Makri E; Cholongitas E; Tziomalos K
World J Gastroenterol; 2016 Nov; 22(41):9039-9043. PubMed ID: 27895393
[TBL] [Abstract][Full Text] [Related]
11. Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Golabi P; Bush H; Younossi ZM
Clin Liver Dis; 2017 Nov; 21(4):739-753. PubMed ID: 28987260
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of non-alcoholic fatty liver disease].
Heebøll S; Vilstrup H; Grønbæk H
Ugeskr Laeger; 2018 Jul; 180(31):. PubMed ID: 30064623
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials.
Zhou J; Chen Y; Yu J; Li T; Lu Z; Chen Y; Zhang X; Ye F
Medicine (Baltimore); 2021 Mar; 100(12):e24884. PubMed ID: 33761646
[TBL] [Abstract][Full Text] [Related]
14. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.
Federico A; Zulli C; de Sio I; Del Prete A; Dallio M; Masarone M; Loguercio C
World J Gastroenterol; 2014 Dec; 20(45):16841-57. PubMed ID: 25492998
[TBL] [Abstract][Full Text] [Related]
15. A Critical Approach of Guideline Therapeutic Recommendations for NAFLD.
Djordjevic DB; Zdravkovic M; Nagorni A; Manolis A; Tsioufis C; Lovic D
Curr Vasc Pharmacol; 2018; 16(3):228-238. PubMed ID: 28676026
[TBL] [Abstract][Full Text] [Related]
16. Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.
Rotman Y; Sanyal AJ
Gut; 2017 Jan; 66(1):180-190. PubMed ID: 27646933
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological treatment of NASH].
Serfaty L
Presse Med; 2019 Dec; 48(12):1489-1495. PubMed ID: 31757735
[TBL] [Abstract][Full Text] [Related]
18. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Staels B; Rubenstrunk A; Noel B; Rigou G; Delataille P; Millatt LJ; Baron M; Lucas A; Tailleux A; Hum DW; Ratziu V; Cariou B; Hanf R
Hepatology; 2013 Dec; 58(6):1941-52. PubMed ID: 23703580
[TBL] [Abstract][Full Text] [Related]
19. Current management of non-alcoholic fatty liver disease.
Lisboa QC; Costa SM; Couto CA
Rev Assoc Med Bras (1992); 2016 Dec; 62(9):872-878. PubMed ID: 28001263
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment.
Oh H; Jun DW; Saeed WK; Nguyen MH
Clin Mol Hepatol; 2016 Sep; 22(3):327-335. PubMed ID: 27729634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
